ELI LILY (LLY) Q4 2024 earnings

Eli Lilly reported mixed results for the fourth quarter on Thursday, even when the demand for its great success of…

CEO Lars Fruergaard Jorgensen discusses Wegovy

They have been a few rocky months to Novo Nordisk. IQVIA prescription data suggest that the Novo Wegovy Obesity Medication…